Back to search

Article

Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma

2026-04-30

Abstract excerpt

<h4>Background: </h4> /Objectives: Clear cell renal cell carcinoma (ccRCC), the predominant malignant subtype of kidney cancer, is the leading cause of death among renal cell carcinoma patients. Although a subset of ccRCC patients benefit from select immune checkpoint inhibitors (ICIs), prognosis remains poor. While PD-1 and PD-L1 have been extensively studied, the prevalence and distribution of other immune check...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b53ce9e9-c232-5308-b455-29c9b2dd678d
DOI
10.20944/preprints202604.2137.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell CarcinomaDOI 10.20944/preprints202604.2137.v1
Select a neighboring publication to make it the new centre.